ViroGates AS (OCSE:VIRO) Institutional Ownership: 0.32% (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCSE:VIRO ViroGates AS OCSE:VIRO
53 GF Score
Price kr9.50
GF Value kr6.67
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is ViroGates AS Institutional Ownership?

ViroGates AS OCSE:VIRO +4.97% 53 Institutional Ownership is 0.32% as of Jul. 29, 2026. GuruFocus rates OCSE:VIRO with a GF Score™ of 53/100 and a GF Value™ of kr6.67 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ViroGates AS's institutional ownership is 0.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ViroGates AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ViroGates AS's Float Percentage Of Total Shares Outstanding is 0.00%.

ViroGates AS Institutional Ownership Historical Data

* Premium members only.

The historical data trend for ViroGates AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViroGates AS Institutional Ownership Chart

ViroGates AS Historical Data

The historical data trend for ViroGates AS can be seen below:

2022-02-28 2022-03-31 2022-04-30 2022-05-31 2022-06-30 2022-07-31 2022-08-31 2022-09-30
Institutional Ownership 0.32 0.32 0.32 0.34 0.34 0.32 0.32 0.32
OCSE:VIRO
53GF Score
ViroGates AS OCSE:VIRO
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ViroGates AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.32% mean?
ViroGates AS (OCSE:VIRO) has a Institutional Ownership of 0.32% as of Jul. 29, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on ViroGates AS and its competitors.
Is ViroGates AS's Institutional Ownership too high?
ViroGates AS's current Institutional Ownership is 0.32%. Overall, ViroGates AS has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ViroGates AS's Institutional Ownership compare to ABT and SYK?
ViroGates AS's Institutional Ownership of 0.32% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on ViroGates AS and its competitors. ViroGates AS's current Institutional Ownership is 0.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViroGates AS stock overvalued right now?
Based on GuruFocus' analysis, ViroGates AS (OCSE:VIRO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr6.67, compared to a current price of kr9.50 — trading 42.4% above its estimated fair value. The current Institutional Ownership is 0.32%. ViroGates AS's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For ViroGates AS (OCSE:VIRO), the current Institutional Ownership is 0.32% as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ViroGates AS (OCSE:VIRO) Overvalued in 2026?

Based on GuruFocus' analysis, ViroGates AS stock appears to be overvalued. The current stock price of kr9.50 is trading 42.4% above its estimated GF Value™ of kr6.67. GuruFocus considers ViroGates AS to be Significantly Overvalued.

Key valuation signals for OCSE:VIRO:

  • Institutional Ownership: 0.32%
  • GF Value™: kr6.67 vs. price of kr9.50 (42.4% above fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the OCSE:VIRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ViroGates AS Business Description

Address Banevaenget 13, Birkerod, DNK, 3460
ViroGates AS is an international medical technology company that develops and markets blood tests to measure chronic inflammation at health clinics and hospitals. The company markets its blood test products under the suPARnostic brand. Its product portfolio comprises suPARnostic TurbiLatex, suPARnostic Quick Triage, and suPARnostic Auto Flex ELISA kit. These products are mainly used to measure the suPAR (soluble urokinase Plasminogen Activator Receptor) protein in the bloodstream.
53GF Score

Get the complete analysis for OCSE:VIRO

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.50
Price
kr6.67
GF Value